Breast Flashcards
Breast Cancer: prognosis
- PT. RELATED & TUMOUR RELATED - younger pt. has worse prognosis
- NODE STATUS = BEST PROGNOSTIC INDICATOR
- TUMOUR SIZE (< 2cm)
- TYPE
- GRADE
- AGE
- LYMPHOVASCULAR SPACE INVASION
- OESTROGEN & PROGESTERONE RECEPTORS - if +ve, they’re strong indicators of response to hormonal therapies; -ve tumours don’t respond
- HER-2 - 20 - 30% +ve respond to trastuzumab
- PROLIFERATIVE RATE of TUMOUR
- GENE EXPRESSION PROFILING - 4 subtypes, can
- NOTTINGHAM PROGNOSTIC INDEX based on TUMOUR SIZE, GRADE, NODAL STATUS
Breast Cancer: presentation
ASYMPTOMATIC - picked up on breast screening (50 - 70 yrs every 3 yrs)
Symptomatic - outpatient clinic for triple assessment of clinical examination, imaging, FNA cytology
* LUMP = FIXED HARD MASS, ABNORMAL CONTOURS * MASTALGIA = PERSISTENT UNILATERAL PAIN, generally breast cancer not painful - hx = cyclical, persistent, unilateral, bilateral * NIPPLE DISCHARGE = BLOOD-STAINED/BLEEDING * NIPPLE CHANGES = PAGET'S DISEASE, INVERSION, RETRACTION * AREOLA = COLOUR/APPEARANCE CHANGE e.g. CRUSTING * BREAST SIZE/SHAPE CHANGE * LYMPHOEDEMA = arm swelling, due to metastasis to lymph nodes, blocks lymphatic drainage - lymph cannot drain from periphery * REDNESS or PITTING/DIMPLING of BREAST SKIN = PEAU D'ORANGE
Breast Cancer: risk factors
Breast cancer:
• GENDER (F > M)
• AGE (increasing age)
• MENSTRUAL Hx (EARLY MENARCHE + LATE MENOPAUSE increases risk)
• AGE at 1ST PREGNANCY (late in life w/o lactation - increases risk; LATE/NO PREGNANCY)
• RADIATION e.g. investigations, rx for cancer, lymphoma, post-RT rx for Hodgkin’s lymphoma
• FHx (esp. 1st degree relatives)
• PMHx e.g. previous breast cancer
• HORMONAL Rx (HRT, some contraceptive pills)
• GENETIC FACTORS (BRCA1, BRCA 2, OTHER GENES)
• OTHER FACTORS = OBESITY, LACK of PHYSICAL ACTIVITY, ALCOHOL (> 14 units/week)
Disease recurrence:
• LYMPH NODE INVOLVEMENT
- TUMOUR GRADE
- TUMOUR SIZE
- STEROID RECEPTOR STATUS (negativity - ER/PR -ve)
- HER2 STATUS (positivity - HER2 +ve)
- LYMPHOVASCULAR INVASION (LVI)
1ST 3 = NPI (prognostic indicator)
Breast Cancer: histological classification
non-invasive - DCIS, LCIS (pre-invasive - not palpable + does not breach duct membrane)
* DCIS = FOCAL - excision w/ wide margins can be curative * LCIS = MULTIFOCAL - MONITOR & FOLLOW-UP PT. as cannot remove all affected tissue • NO METASTATIC SPREAD RISK of INVASION DEPENDS on GRADE
invasive - invasive ductal carcinoma (80%), invasive lobular carcinoma + its variants (10%), special types (10%) e.g. tubular carcinoma, mucinous carcinoma
Breast Cancer: investigations/diagnosis
Screening every 3 yrs w/ mammography for those whoa re 50 - 70yrs
CLINICAL - Hx + examination
RADIOLOGY - bilateral mammogram, USS, MRI
CYTOPATHOLOGICAL - FNAC, NEEDLE CORE BIOPSY (grading, invasion, tumour type, hormonal receptors)
WIDE LOCAL EXCISION w/ ADEQUATE MARGINS
Breast Cancer: management
DIAGNOSE DISEASE
STAGE DISEASE = BLOODS (FBC, U+E, LFTs, Ca2+/PO2-), IMAGING (CXR, CT CHEST/ABDO/PELVIS), no reliable tumour markers - TNM STAGING
DEFINITIVE Rx:
MDT APPROACH
SURGERY - WLE +/- LYMPH NODES, BREAST CONSERVATION SURGERY, MASTECTOMY, SURGERY to AXILLA
+/-RT
+/-CHEMOTHERAPY
+/- HORMONAL THERAPY (trastuzumab, tamoxifen, letrozole)
Breast Cancer: spread
- LOCAL = SKIN, PECTORAL MUSCLES
- LYMPHATIC = AXILLARY, INTERNAL MAMMARY NODES
- BLOOD = BONE, LUNGS, LIVER, BRAIN
Male breast: gynaecomastia
- Most common clinical & pathological abnormality of male breast
- INCREASE in SUBAREOLAR TISSUE
- BOTH BREASTS CAN BE AFFECTED
- ASS W/:
- HYPERTHYROIDISM
- LIVER CIRRHOSIS
- CHRONIC RENAL FAILURE
- CHRONIC PULMONARY DISEASE
- HYPOGONADISM
- HORMONAL USE e.g. oestrogens, androgens, other drugs e.g. digitalis, cimetidine, spironolactone, marijuana, tricyclic antidepressants
Male breast: carcinoma
• SAME PRESENTATION AS FEMALES - tends to be LATE STAGE INVASIVE DUCTAL CARCINOMA due to LACK of FIBROADENOMATOUS BARRIER bwtn nipple & chest wall
Paget’s disease of nipple
- Result of INTRA-EPITHELIAL SPREAD of INTRADUCTAL CARCINOMA
- Large pale-staining cells w/I epidermis of nipple
○ Can also have ULCERATION, CRUSTING, SEROUS/BLOODY DISCHARGE
- BILATERAL = ECZEMA, INFLAMMATION
- UNILATERAL = CARCINOMA
Breast development (in utero)
- MAMMARY CRESTS/RIDGES APPEAR during 4TH WEEK - they EXTEND from AXILLARY REGION to INGUINAL REGION + usually DISAPPEAR EXCEPT in PECTORAL REGION
- PRIMARY MAMMARY BUDS - SECONDARY BUDS - LACTIFEROUS DUCTS & THEIR BRANCHES (COMPOUND ACINOALVEOLAR GLANDS - multiple branchings from 1 point)
Age-related changes of breast
Pre-puberty:
• Neonatal breast contain LACTIFEROUS DUCTS + NO ALVEOLI
• LITTLE BRANCHING of ducts occurs until puberty
• SLIGHT BREAST ENLARGEMENT reflects FIBROUS STROMA & FAT GROWTH
Puberty:
• LACTIFEROUS DUCTS BRANCH
• ALVEOLI FORM (solid, spheroidal masses of granular polyhedral cells)
• LIPIDS ACCUMULATE in ADIPOCYTES
Post-menopausal:
• PROGRESSIVE ATROPHY of LOBULES & DUCTS
• FATTY REPLACEMENT of GLANDULAR TISSUE
Mammography
STANDARD VIEWS
* MEDIOLATERAL OBLIQUE (MLO) * CRANIOCAUDAL (CC)
INDICATIONS:
* > 40YRS * < 40 YRS if STRONG SUSPICION of CANCER, FHx RISK > 40% SMALL DOSE of RADIATION
CANCER SEEN AS:
* MASS * ASYMMETRY * ARCHITECTURAL DISTORTION * CALCIFICATIONS * SKIN CHANGES
USS
- DIFFERENTIATE: SOLID from CYSTIC; BENIGN from MALIGNANT
- 1ST LINE IMAGING if < 40YRS
- NO RADIATION
- IMPROVES SPECIFICITY of IMAGING (if using w/ mammogram)
- But DOESN’T PROVIDE SAME INFO as MAMMOGRAM (so need to do both)
MRI
NDICATIONS:
* RECURRENT DISEASE * IMPLANTS (silicone appear white - can check for leaks) * INDETERMINATE LESION following TRIPLE ASSESSMENT * SCREENING HIGH RISK WOMEN • HIGH SENSITIVITY + POOR SPECIFICITY (lots of issues incl. benign issues can show up)
DISADVANTAGES:
* CLAUSTROPHOBIC, NOISY, LENGTHY, IV CONTRAST * EXPENSIVE